ESC 365 - Session key takeaways - Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Open Access

Session key takeaways - Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Session: Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Topic: Treatment

Speaker: Professor M. Gilard (Brest, FR)

Sponsored by Edwards Lifesciences

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Martine Gilard

Hospital Cavale Blanche, Brest (France)

23 presentations

7 followers

5 more presentations in this session

Introduction and learning objective - Current minimally-invasive treatment modalities for heart valve diseases: what is next?

Speaker: Professor M. Gilard (Brest, FR)

The burden of structural heart valve diseases - Incidence, Prevalence, Treatment Pathways, Quality of Care in the EU.

Speaker: Professor B. Prendergast (London, GB)

What are current and future treatment modalities? A tailored approach - Aortic stenosis

Speaker: Professor H. Moellmann (Dortmund, DE)

What are current and future treatment modalities? A tailored approach - Mitral regurgitation

Speaker: Doctor A. Latib (New York, US)

What are current and future treatment modalities? A tailored approach - Tricuspid regurgitation

Speaker: Doctor M. Enriquez-Sarano (Minneapolis, US)

Access the full session

Current minimally-invasive treatment modalities for heart valve diseases : what is next?

Speakers: Professor M. Gilard, Professor M. Gilard, Professor B. Prendergast, Professor H. Moellmann, Doctor A. Latib...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources